Home/Filings/4/0001235802-11-000118
4//SEC Filing

Erickson Whitney 4

Accession 0001235802-11-000118

CIK 0001114200other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 12:04 PM ET

Size

23.6 KB

Accession

0001235802-11-000118

Insider Transaction Report

Form 4
Period: 2011-06-17
Erickson Whitney
VP, General Mgr, Men's Health
Transactions
  • Disposition to Issuer

    Common Stock

    2011-06-1710,135.9217,290 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-1712,14236,428 total
    Exercise: $18.46Exp: 2017-02-11Common Stock (12,142 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17130,0000 total
    Exercise: $19.95Exp: 2014-01-30Common Stock (130,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-1720,0000 total
    Exercise: $18.66Exp: 2017-11-22Common Stock (20,000 underlying)
  • Disposition to Issuer

    Common Stock

    2011-06-177,2900 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-1736,4280 total
    Exercise: $18.46Exp: 2017-02-11Common Stock (36,428 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-1745,7700 total
    Exercise: $20.05Exp: 2018-02-10Common stock (45,770 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-1750,0000 total
    Exercise: $10.82Exp: 2016-02-09Common Stock (50,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-1740,0000 total
    Exercise: $14.36Exp: 2015-03-05Common Stock (40,000 underlying)
Footnotes (9)
  • [F1]Pursuant to the merger of a wholly-owned subsidiary of Endo Pharmaceutials Holdings Inc. ("Endo") with and into American Medical Systems Holdings, Inc. (the "Merger"), such shares were disposed of in exchange for $304,077.63 in cash.
  • [F2]These restricted shares were assumed by Endo in the Merger in exchange for 5,507 restricted shares of Endo common stock, having a market value of $38.32 per share on the effective date of the Merger. The vesting terms of the new Endo restricted stock grants will remain the same as the vesting terms of the old grants.
  • [F3]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $1,306,500 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F4]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $625,800 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F5]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $958,750 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F6]This option, which vested with respect to 25% of the shares on March 31, 2011 and with respect to the remaining shares, quarterly over the next three years, was canceled with respect to 12,142 shares in the Merger in exchange for a cash payment of $140,118.68 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F7]This option, which vested with respect to 25% of the shares on March 31, 2011 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 27,521 shares of Endo common stock with an exercise price of $24.44 per share.
  • [F8]This option, which vested with respect to 25% of the shares on December 31, 2011 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 15,110 shares of Endo common stock with an exercise price of $24.70 per share.
  • [F9]This option, which vested with respect to 25% of the shares on March 31, 2012 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 34,579 shares of Endo common stock with an exercise price of $26.54 per share.

Issuer

AMERICAN MEDICAL SYSTEMS HOLDINGS INC

CIK 0001114200

Entity typeother

Related Parties

1
  • filerCIK 0001389691

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 12:04 PM ET
Size
23.6 KB